Artificial intelligence influences every aspect of our lives and creates revolutionary effects in the pharmaceutical industry as well as in many other sectors. From DeepMind's AlphaGo success to Tempus' personalized approaches to cancer treatment, AI-enabled innovations offer not only scientific achievements, but also wide-ranging advantages such as operational efficiency, cost reduction and risk reduction. However, this technological leap also raises critical questions about the traditional processes of the pharmaceutical industry and the patent system.
Authors:
Selin Sinem Erciyas, Partner
Email: selin.erciyas@gun.av.tr
Zeynep Çağla Üstün, Managing Associate
Email: zeynep.ozcebe@gun.av.tr